Human IL-2 R beta/IL-2 R gamma (Luc) HEK293 Reporter Cell

Cat. No. / Size
Price
Qty
CHEK-ATF136-2Vials (1Vial X 2)
$15220.00
ETA of in-stock products:2 business days

Product Details

    1. Genetically modified cell lines best reflect MOA (Mechanism of Action)
    2. Higher activity and larger assay window for robust and reproducible cell-based bioassay
    3. Comprehensive application data to support assay development and validation
    4. Full tracible record, stringent quality control and validated cell passage stability
    5. Parental cell line legally obtained from internationally recognized cell resource bank and commercially licensed
    6. Global commercial license assistance whenever regulatory filing is required
  • Description

    The Human IL-2 R beta/IL-2 R gamma (Luc) HEK293 Reporter Cell was engineered to not only express STAT5 signaling response element, but also express the receptors full length human IL-2 R beta (Uniprot: P14784) and IL-2 R gamma (Uniprot: P31785-1). When stimulated with human IL-2 protein, receptor-mediate signaling drives STAT5-mediated luminescence.

  • Application

    • Bioactivity detection of human IL-2 fusion protein

    • Bioactivity detection of human IL-15 fusion protein

    IL-2 R beta & IL-2 R gamma Assay Principles

  • Growth Properties

    Adherent

  • Selection Marker

    Puromycin (2 μg/mL) + Zeocin (20 μg/mL) + G418 (200 μg/mL)

  • Complete Growth Medium

    DMEM + 10% FBS

  • Freeze Medium

    Serum-free cell cryopreservation medium

  • Quantity

    1 vial contains at least 5×10^6 cells in 1 mL serum-free cryopreservation medium

  • Storage

    Frozen in liquid nitrogen.

  • Mycoplasma Testing

    Negative

  • Sterility Testing

    Negative

  • Instructions for Use

    See data sheet for detailed culturing and assay protocol.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • Receptor Assay

     IL-2 R beta & IL-2 R gamma FACS

    Co-expression analysis of human IL-2 R beta and IL-2 R gamma on Human IL-2 R beta/IL-2 R gamma (Luc) HEK293 Reporter Cell by FACS.
    Cell surface staining was performed on Human IL-2 R beta/IL-2 R gamma (Luc) HEK293 Reporter Cell or negative control cell using PE-labeled anti-IL-2 R beta antibody and APC-labeled anti-IL-2 R gamma antibody.

    Protocol
  • Signaling Bioassay

     IL-2 R beta & IL-2 R gamma SIGNALING

    Response to human IL-2 protein (RLU).
    The Human IL-2 R beta/IL-2 R gamma (Luc) HEK293 Reporter Cell was stimulated with serial dilutions of human IL-2 protein (Cat. No. IL2-H5215). The EC50 was approximately 0.0025 μg/mL.

    Protocol
  •  IL-2 R beta & IL-2 R gamma SIGNALING

    Response to human IL-2 protein (FOLD).
    The Human IL-2 R beta/IL-2 R gamma (Luc) HEK293 Reporter Cell was stimulated with serial dilutions of human IL-2 protein (Cat. No. IL2-H5215). The max induction fold was approximately 99.74.

    Protocol
*Please contact us if you are interested in related cell pool service.

Customer Reviews
Writing Reviews

Important Statement

  • LIMITED USE AND LICENSE STATEMENT

    HEK293 Cell Line Products

    By using any HEK293 cell line product purchased from ACRO Biosystems or its affiliates (collectively, "ACROBiosystems"), including the original 293 cells and any modified derivatives thereof (collectively, the "Product"), you (the "Customer") agree to be bound by the following terms of limited use. If you are not willing to accept these terms and the Product remains unused, please contact our customer service at customerservice@acrobiosystems.com to arrange for return of the unused Product for a refund.

    • 1. Scope of Use

      For the use of the Product worldwide (excluding Mainland China, Hong Kong, Macao and Taiwan regions), Customer may use the Product for (i) internal research; (ii) drug discovery and assay development; (iii) internal quality assurance testing for biologic drugs and vaccines; and (iv) lot releasing assay for biologic drugs and vaccines, whether conducted by a commercial or non-commercial entity. Unless a separate sublicense has been obtained, it is NOT permitted to use the Product in (i) product manufacturing; (ii) provision of service, information, or data to an unaffiliated third party for a fee; (iii) resale of the Product or its derivatives, whether or not such Product or derivatives are resold for use in research or (iv) other commercial use not expressly permitted above.


      For the use of the Product in Greater China region (including Mainland China, Hong Kong, Macao and Taiwan regions), Customer may use the Product for internal research use only. Unless a separate sublicense has been obtained, it is NOT permitted to use the Product for any Commercial Use. For the purpose of this paragraph, "Commercial Use" means any and all uses of this product and derivatives by a party for profit or other consideration and may include but is not limited to use in: (i) product manufacture; (ii) provision of service, information or data to a third party for a fee; (iii) resale of the product or its derivatives, whether or not such Product or derivatives are resold for use in research; (iv) quality assurance testing for biologic drugs and vaccines; (v) quality control assays; (vi) lot releasing assay of biologic drugs and vaccines.


      If you require a sublicense for any use beyond the limited use permitted herein, including but not limited to commercial use, CRO/service provider activities for a fee, or any product manufacturing activities, please contact the local sales team of ACROBiosystems for further details.


      The Product is not intended for any animal or human therapeutic purposes, nor for any direct human in vivo use. The Product shall not be used in or administered to humans.

    • 2. Transfer, Distribution and Sublicensing Restrictions

      Unless expressly permitted under a separate written agreement with/via ACROBiosystems, you have NO right to (i) share, transfer, distribute, sell, resell, sublicense, or otherwise make the Product or its derivatives available for use to any third party, including but not limited to other researchers, laboratories, departments, research institutions, hospitals, universities, contract research organizations (CROs), contract development and manufacturing organizations (CDMOs), or any other commercial entities; or (ii) use the Product or its derivatives to perform fee-for-service activities or to provide services, information, or data to any third party for monetary or other consideration.

    • 3. Modification and Derivatives

      Customers have No right to modify, engineer, genetically alter, or create derivatives of the Product. Any such modification or derivative requires a separate license and additional fees. Please contact our local sales team for further details.

    • 4. No Warranty

      ACROBiosystems makes no warranties or representations of any kind, either expressed or implied, with respect to the merchantability, fitness or suitability of the Product for any particular purpose.

    • 5. Limitation of Liability

      To the fullest extent permitted by law, in no event shall ACROBiosystems or its licensors be liable for any use by Customer of the Product, any derivative thereof, or any material treated therewith for any losses, costs, claims, damages, or liability of whatsoever kind or nature which may arise from or in connection with the use of the Product.

    • 6. Compliance with Laws

      Customer agrees to use the Product in compliance with all applicable laws, regulations, and governmental guidelines applicable to the Product, any derivative thereof, and any materials treated therewith.

    ACKNOWLEDGMENT

    By using this Product, Customer acknowledges that he/she has read, understood, and agreed to be bound by the terms and conditions of this Limited Use and License Statement. If Customer does not agree to comply with these terms, Customer shall not open or use the Product and shall contact ACROBiosystems to arrange for return of the unused Product.

Recent Advances

 
Drug Development Progress
  • English Name:

    Interleukin-2 receptor subunit gamma

  • Category:

  • Approved Drugs:

    0 Details

  • Drugs in Clinical Trials:

    14 Details

  • Highest Development Stage:

    Phase 2 Clinical

Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Important Statement